Suppr超能文献

重组人戈利木单抗对顺铂诱导的小鼠肾炎症的改善作用。

Amelioration of Cisplatin-induced Renal Inflammation by Recombinant Human Golimumab in Mice.

机构信息

Division of Biotechnology, Lupin Limited, Pune, India.

Faculty of Health Sciences, Symbiosis School of Biological Sciences, Selvan Ravindran, Symbiosis International (Deemed) University, Pune, India.

出版信息

Curr Pharm Biotechnol. 2022;23(7):970-977. doi: 10.2174/1389201022666210810141139.

Abstract

BACKGROUND

One of the most commonly used anti-cancer agents, Cisplatin (CDDP) often causes nephrotoxicity by eliciting inflammation and oxidative stress. Golimumab, an anti-TNF biologic, is prescribed for the management of numerous inflammatory ailments like psoriatic and rheumatoid arthritis, ulcerative colitis and ankylosing spondylitis.

OBJECTIVE

Current study has explored the effects of anti-TNF biologics golimumab on mice due to cisplatin-induced nephrotoxicity.

METHOD

Renal toxicity was caused by administration of single cisplatin injection at 22 mg/kg by intraperitoneal (i/p) route. Golimumab (24 mg/kg, s.c.) was administered consecutively for 7 days. The parameters such as renal functions, oxidative stress, inflammation, and renal damage were evaluated on the 7th day of experiments.

RESULTS

Cisplatin administration caused nephrotoxicity as shown by a significant elevation of various parameters viz; serum creatinine, neutrophil gelatinase-associated lipocalin (NGAL), urea nitrogen (BUN), and cystatin C. There was a significant rise in urinary clusterin, kidney injury molecule 1 (KIM-1), and β-N-acetylglucosaminidase (NAG) concentrations in the animals treated with cisplatin. The markers of oxidative stress (malondialdehyde, reduced glutathione, and catalase), inflammation (IL-6, TNF-α, IL-10, IL-1β, MCP-1, ICAM-1, and TGF-β1), and apoptosis (caspase-3) were also altered in serum and/or kidneys of cisplatin animals. Further, cisplatin-caused histopathological changes in proximal tubular cells as observed in the H&E staining of renal tissue. Golimumab treatment reduced all markers of kidney injury and attenuated cell death. Golimumab significantly reduced inflammatory cytokines TNFα, IL- 6, MCP-1, IL- 1β, ICAM-1, and TGF-β1 and increased anti-inflammatory cytokine IL-10 in cisplatin-intoxicated mice.

CONCLUSION

The study's results suggest that golimumab prevented nephrotoxicity induced by cisplatin- through inhibition of oxidative stress, apoptotic cell death inflammatory response, thus improving renal function.

摘要

背景

顺铂(CDDP)是最常用的抗癌药物之一,常通过引发炎症和氧化应激引起肾毒性。戈利木单抗是一种抗 TNF 生物制剂,用于治疗多种炎症性疾病,如银屑病关节炎、类风湿关节炎、溃疡性结肠炎和强直性脊柱炎。

目的

本研究探讨了抗 TNF 生物制剂戈利木单抗对顺铂诱导的肾毒性小鼠的影响。

方法

通过腹腔内(i/p)途径给予单剂量顺铂 22mg/kg 造成肾毒性。连续 7 天给予戈利木单抗(24mg/kg,皮下)。在实验的第 7 天评估肾功能、氧化应激、炎症和肾损伤等参数。

结果

顺铂给药导致肾毒性,表现为各种参数显著升高,如血清肌酐、中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、尿素氮(BUN)和胱抑素 C。顺铂处理的动物尿中簇蛋白、肾损伤分子 1(KIM-1)和 β-N-乙酰氨基葡萄糖苷酶(NAG)浓度显著升高。血清和/或肾脏中的氧化应激标志物(丙二醛、还原型谷胱甘肽和过氧化氢酶)、炎症标志物(IL-6、TNF-α、IL-10、IL-1β、MCP-1、ICAM-1 和 TGF-β1)和凋亡标志物(caspase-3)也发生改变。此外,顺铂引起的组织病理学变化在肾组织的 H&E 染色中观察到近端肾小管细胞。戈利木单抗治疗降低了所有肾损伤标志物,并减轻了细胞死亡。戈利木单抗显著降低了顺铂中毒小鼠的炎症细胞因子 TNFα、IL-6、MCP-1、IL-1β、ICAM-1 和 TGF-β1,并增加了抗炎细胞因子 IL-10。

结论

该研究结果表明,戈利木单抗通过抑制氧化应激、细胞凋亡、炎症反应,防止顺铂引起的肾毒性,从而改善肾功能。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验